|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,429.00 GBX | +1.06% |
|
+1.38% | +6.13% |
| 03:10pm | GSK: to present new data on HIV | CF |
| 01:28pm | Europe rises despite new US tariff mayhem | AN |
| Capitalization | 5.72TCr 7.76TCr 6.63TCr 6.19TCr 11TCr 6,65800Cr 12TCr 74TCr 28TCr 3,10600Cr 29TCr 29TCr 11,39300Cr | P/E ratio 2025 * |
9.91x | P/E ratio 2026 * | 8.77x |
|---|---|---|---|---|---|
| Enterprise value | 7.04TCr 9.55TCr 8.16TCr 7.61TCr 13TCr 8,19500Cr 15TCr 91TCr 35TCr 3,82300Cr 36TCr 35TCr 14,02300Cr | EV / Sales 2025 * |
2.19x | EV / Sales 2026 * | 2x |
| Free-Float |
94.52% | Yield 2025 * |
4.6% | Yield 2026 * | 4.9% |
More valuation ratios
* Estimated data
More news
Last Transcript: GSK plc
More press releases
More news
| 1 day | +1.13% | ||
| 1 week | +1.38% | ||
| Current month | +2.81% | ||
| 1 month | -5.30% | ||
| 3 months | +13.05% | ||
| 6 months | +5.89% | ||
| Current year | +6.13% |
| 1 week | 1,380.5 |  | 1,430.5 |
| 1 month | 1,380.5 | | 1,557 |
| Current year | 1,242.5 | | 1,560.5 |
| 1 year | 1,242.5 | | 1,678.68 |
| 3 years | 1,242.5 | | 2,215 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 56 | 01/04/2017 |
Julie Brown
DFI | Director of Finance/CFO | 63 | 01/05/2023 |
James Ford
CMP | Compliance Officer | - | 01/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Emma Walmsley
BRD | Director/Board Member | 56 | 01/01/2017 |
Hal Barron
BRD | Director/Board Member | 63 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 67 | 01/09/2019 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 3.15% | 21 M€ | +3.63% | - | |
| 2.97% | 57 M€ | +13.05% | - | |
| 2.51% | 7 M€ | +12.99% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.06% | +1.38% | -5.36% | -35.37% | 7.76TCr | ||
| +0.98% | +0.89% | -15.69% | +137.47% | 70TCr | ||
| -0.29% | -0.10% | +5.68% | -12.87% | 37TCr | ||
| -0.25% | -0.73% | +12.67% | +23.57% | 34TCr | ||
| -1.53% | +0.35% | -54.14% | +9.26% | 31TCr | ||
| +0.89% | -0.42% | +5.89% | -20.66% | 26TCr | ||
| -0.16% | -0.85% | +0.51% | +17.58% | 24TCr | ||
| +0.23% | -0.27% | -13.25% | -7.10% | 22TCr | ||
| +2.71% | +1.15% | -33.88% | -11.63% | 20TCr | ||
| -0.23% | -0.05% | -6.08% | +19.74% | 16TCr | ||
| Average | +0.30% | +0.52% | -10.36% | +12.00% | 28.8TCr | |
| Weighted average by Cap. | +0.24% | +0.39% | -10.79% | +33.79% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.21TCr 4.36TCr 3.72TCr 3.47TCr 5.96TCr 3,74000Cr 6.68TCr 42TCr 16TCr 1,74500Cr 16TCr 16TCr 6,39900Cr | 3.4TCr 4.61TCr 3.93TCr 3.67TCr 6.3TCr 3,95100Cr 7.06TCr 44TCr 17TCr 1,84300Cr 17TCr 17TCr 6,76200Cr |
| Net income | 572Cr 775.84Cr 662.65Cr 618.47Cr 1.06TCr 67TCr 1.19TCr 7.41TCr 2.81TCr 31TCr 2.91TCr 2.85TCr 1,13900Cr | 646.1Cr 876.35Cr 748.49Cr 698.59Cr 1.2TCr 75TCr 1.34TCr 8.37TCr 3.18TCr 35TCr 3.29TCr 3.22TCr 1,28700Cr |
| Net Debt | 1.32TCr 1.79TCr 1.53TCr 1.43TCr 2.45TCr 1,53700Cr 2.75TCr 17TCr 6.5TCr 72TCr 6.72TCr 6.58TCr 2,63000Cr | 1.06TCr 1.44TCr 1.23TCr 1.14TCr 1.96TCr 1,23100Cr 2.2TCr 14TCr 5.2TCr 57TCr 5.38TCr 5.27TCr 2,10700Cr |
More financial data
* Estimated data
Employees
68,629
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/25/09 | 1,429.00 p | +1.06% | 32,37,962 |
| 08/25/08 | 1,414.00 p | +1.33% | 62,47,440 |
| 07/25/07 | 1,395.50 p | -0.68% | 55,18,642 |
| 04/25/04 | 1,405.00 p | +0.79% | 40,05,882 |
| 03/25/03 | 1,394.00 p | -1.10% | 79,26,084 |
Delayed Quote London S.E., July 09, 2025 at 08:59 pm IST
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
14.14GBP
Average target price
16.61GBP
Spread / Average Target
+17.47%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition